Latest Breaking News On - Seshadri neervannan - Page 1 : comparemela.com

Tarsus Pharmaceuticals (NASDAQ:TARS) Shares Up 5 8% After Analyst Upgrade

Tarsus Pharmaceuticals (NASDAQ:TARS) Shares Up 5 8% After Analyst Upgrade
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesSeshadri neervannanBobakr azamianSecurities exchange commissionTarsus pharmaceuticals incTarsus pharmaceuticalsAllspring global investments holdingsIeq capitalSwiss national bankJefferies financial groupInsider transactions at tarsus pharmaceuticalsNews ratings for tarsus pharmaceuticals dailyConnor clark lunn investment management ltdArtisan partners limited partnershipGoldman sachs groupHedge funds weigh in on tarsus pharmaceuticals

Oppenheimer Raises Tarsus Pharmaceuticals (NASDAQ:TARS) Price Target to $61 00

Oppenheimer Raises Tarsus Pharmaceuticals (NASDAQ:TARS) Price Target to $61 00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesAziz mottiwalaSeshadri neervannanFinancial servicesProshare advisorsNews ratings for tarsus pharmaceuticals dailyTarsus pharmaceuticals incTarsus pharmaceuticals company profileAnalyst recommendations for tarsus pharmaceuticalsGoldman sachs groupBleakley financial groupSecurities exchange commissionLord abbettTarsus pharmaceuticals stock performanceTarsus pharmaceuticalsInstitutional trading of tarsus pharmaceuticals

Tarsus Pharmaceuticals, Inc (NASDAQ:TARS) Stake Decreased by Vivo Capital LLC

Tarsus Pharmaceuticals, Inc (NASDAQ:TARS) Stake Decreased by Vivo Capital LLC
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesZurcher kantonalbank zurich cantonalbankSeshadri neervannanBryan wahlMirae asset global investments coTarsus pharmaceuticals incHoldings channelGoldman sachs groupTarsus pharmaceuticals stock performanceNews ratings for tarsus pharmaceuticals dailyTarsus pharmaceuticals profileJefferies financial groupChina universal asset management coVivo capitalQuarter for tarsus pharmaceuticalsRaymond james associates

Tarsus Pharmaceuticals (NASDAQ:TARS) PT Raised to $61 00

Tarsus Pharmaceuticals (NASDAQ:TARS) PT Raised to $61 00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesZurcher kantonalbank zurich cantonalbankSeshadri neervannanBryan wahlHedge funds weigh in on tarsus pharmaceuticalsAnalyst recommendations for tarsus pharmaceuticalsTarsus pharmaceuticals incTarsus pharmaceuticals stock downNews ratings for tarsus pharmaceuticals dailyRaymond james associatesIeq capitalChina universal asset management coGoldman sachs groupTower research capitalJefferies financial groupTarsus pharmaceuticals